載入...
Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma
Over the last seven years, seven targeted agents have been approved in the treatment of advanced or metastatic renal cell cancer, changing the therapeutic approach and prognosis of the disease dramatically. The latest agent with demonstrated efficacy is axitinib (Inlyta(®)). This new generation of t...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Libertas Academica
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3825605/ https://ncbi.nlm.nih.gov/pubmed/24250243 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMO.S10594 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|